Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase
- 31 May 2007
- journal article
- review article
- Published by Elsevier BV in Journal of Molecular and Cellular Cardiology
- Vol. 42 (5), 903-911
- https://doi.org/10.1016/j.yjmcc.2007.03.738
Abstract
No abstract availableThis publication has 83 references indexed in Scilit:
- Defining the Intramembrane Binding Mechanism of Sarcolipin to Calcium ATPase Using Solution NMR SpectroscopyJournal of Molecular Biology, 2006
- Post-transcriptional downregulation of sarcolipin mRNA by triiodothyronine in the atrial myocardiumFEBS Letters, 2006
- Targeted Overexpression of Sarcolipin in the Mouse Heart Decreases Sarcoplasmic Reticulum Calcium Transport and Cardiac ContractilityOnline Journal of Public Health Informatics, 2006
- Down-regulation of sarcolipin mRNA expression in chronic atrial fibrillationEuropean Journal of Clinical Investigation, 2004
- Is Depressed Myocyte Contractility Centrally Involved in Heart Failure?Circulation Research, 2003
- SERCA Pump Level is a Critical Determinant of Ca2+Homeostasis and Cardiac ContractilityJournal of Molecular and Cellular Cardiology, 2001
- Characterization of the Gene Encoding Human Sarcolipin (SLN), a Proteolipid Associated with SERCA1: Absence of Structural Mutations in Five Patients with Brody DiseaseGenomics, 1997
- The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractilityBasic Research in Cardiology, 1997
- Reversal of Phospholamban-Induced Inhibition of Cardiac Sarcoplasmic Reticulum Ca2+-ATPase by TanninBiochemical and Biophysical Research Communications, 1994
- Complete complementary DNA-derived amino acid sequence of canine cardiac phospholamban.JCI Insight, 1987